Ulas Aydin, Kaplan Serife, Zeyneloglu Pinar, Torgay Adnan, Pirat Arash, Haberal Mehmet
From the Department of Anesthesiology, Baskent University Faculty of Medicine, Ankara, Turkey.
Exp Clin Transplant. 2015 Nov;13 Suppl 3:44-7. doi: 10.6002/ect.tdtd2015.O37.
Frequency of pulmonary complications after renal transplant has been reported to range from 3% to 17%. The objective of this study was to evaluate renal transplant recipients admitted to an intensive care unit to identify incidence and cause of acute respiratory failure in the postoperative period and compare clinical features and outcomes between those with and without acute respiratory failure.
We retrospectively screened the data of 540 consecutive adult renal transplant recipients who received their grafts at a single transplant center and included those patients admitted to an intensive care unit during this period for this study. Acute respiratory failure was defined as severe dyspnea, respiratory distress, decreased oxygen saturation, hypoxemia or hypercapnia on room air, or requirement of noninvasive or invasive mechanical ventilation.
Among the 540 adult renal transplant recipients, 55 (10.7%) were admitted to an intensive care unit, including 26 (47.3%) admitted for acute respiratory failure. Median time from transplant to intensive care unit admission was 10 months (range, 0-67 mo). The leading causes of acute respiratory failure were bacterial pneumonia (56%) and cardiogenic pulmonary edema (44%). Mean partial pressure of arterial oxygen to fractional inspired oxygen ratio was 174 ± 59, invasive mechanical ventilation was used in 13 patients (50%), and noninvasive mechanical ventilation was used in 8 patients (31%). The overall mortality was 16.4%.
Acute respiratory failure was the reason for intensive care unit admission in almost half of our renal transplant recipients. Main causes of acute respiratory failure were bacterial pneumonia and cardiogenic pulmonary edema. Mortality of patients admitted for acute respiratory failure was similar to those without acute respiratory failure.
据报道,肾移植后肺部并发症的发生率在3%至17%之间。本研究的目的是评估入住重症监护病房的肾移植受者,以确定术后急性呼吸衰竭的发生率和原因,并比较有和没有急性呼吸衰竭的患者的临床特征和预后。
我们回顾性筛选了在单一移植中心接受移植的540例连续成年肾移植受者的数据,并纳入了在此期间入住重症监护病房的患者进行本研究。急性呼吸衰竭定义为严重呼吸困难、呼吸窘迫、氧饱和度下降、在室内空气中出现低氧血症或高碳酸血症,或需要无创或有创机械通气。
在540例成年肾移植受者中,55例(10.7%)入住重症监护病房,其中26例(47.3%)因急性呼吸衰竭入院。从移植到入住重症监护病房的中位时间为10个月(范围为0至67个月)。急性呼吸衰竭的主要原因是细菌性肺炎(56%)和心源性肺水肿(44%)。平均动脉血氧分压与吸入氧分数比为174±59,13例患者(50%)使用了有创机械通气,8例患者(31%)使用了无创机械通气。总死亡率为16.4%。
急性呼吸衰竭是近一半肾移植受者入住重症监护病房的原因。急性呼吸衰竭的主要原因是细菌性肺炎和心源性肺水肿。因急性呼吸衰竭入院的患者死亡率与无急性呼吸衰竭的患者相似。